Polarean expands XENOVIEW 3T Coil access with Philips compatibility

Immedica gets UAE approval for Zepzelca maintenance treatment

AstraZeneca wins US approval for Imfinzi as first perioperative immunotherapy in early gastric and GEJ cancer

AstraZeneca to invest USD2bn in major Maryland manufacturing expansion

Flagship Pioneering announces new agreements with ProFound Therapeutics and Quotient Therapeutics under GSK collaboration

Nuvalent's zidesamtinib NDA filing accepted by US FDA

BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU

Probi launches new human and pet biotics ranges

European Commission approves Insmed's BRINSUPRI for the treatment of non-cystic fibrosis bronchiectasis

Pulmonary Fibrosis Foundation Launches New Five-Year Strategy: The PFF is ME

Incyte receives positive CHMP opinion for Minjuvi in relapsed or refractory follicular lymphoma

Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s

iLeukon Therapeutics reveals new clinical results for ILKN421H ongoing first-in-human Phase I trial (NCT05978102)

AN2 Therapeutics partners with GSK to develop boron-based TB therapies; Secures Gates Foundation funding

Boehringer Ingelheim receives Commissioner's National Priority Voucher for HERNEXEOS (zongertinib tablets)